Changes Due to Ageing in the Glycan Structure of Alpha-2-Macroglobulin and Its Reactivity with Ligands.


Journal

The protein journal
ISSN: 1875-8355
Titre abrégé: Protein J
Pays: Netherlands
ID NLM: 101212092

Informations de publication

Date de publication:
02 2019
Historique:
pubmed: 20 12 2018
medline: 22 3 2019
entrez: 20 12 2018
Statut: ppublish

Résumé

Alpha-2-macroglobulin (α2M) is a molecule generally associated with inflammation, and chronic inflammation is associated with ageing and cancer. The degree of inflammation was recently proposed to be considered as a biomarker of biological ageing. In this study, glycans attached to α2M were analysed in a human population of different ages by lectin-based protein microarray. Higher reactivity of α2M with several lectins was detected in older individuals indicating an increased content of specific monosaccharides: α2,6 sialic acid, mannose and N-acetylglucosamine, and multiantennary complex type N-glycans. The increased glycosylation of α2M was accompanied by reduced binding of Zn ions and insulin-like growth factor-binding protein 2 (IGFBP-2). Glycosylation of α2M and its reactivity with IGFBP-2 is similarly affected by ageing and incidence of colon cancer, but the reactivity of α2M with Zn ions is differently affected, as the binding of Zn ions remains unaltered in patients with colon cancer compared to healthy middle-aged individuals. Thus, the binding of IGFBP-2 to α2M seems to be related to structural changes in the glycan moieties of α2M, whereas binding of Zn ions, most likely, is not.

Identifiants

pubmed: 30564965
doi: 10.1007/s10930-018-9806-6
pii: 10.1007/s10930-018-9806-6
doi:

Substances chimiques

A2M protein, human 0
IGFBP2 protein, human 0
Insulin-Like Growth Factor Binding Protein 2 0
Polysaccharides 0
alpha-Macroglobulins 0
Zinc J41CSQ7QDS

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

23-29

Subventions

Organisme : Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja
ID : 173042
Pays : International
Organisme : Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja
ID : 451-03-545/2015-09/01
Pays : International
Organisme : Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja
ID : SK-SRB-2016-0023
Pays : International
Organisme : Agentúra Ministerstva školstva, vedy, výskumu a športu SR
ID : VEGA 2/0162/14
Pays : International
Organisme : Agentúra Ministerstva školstva, vedy, výskumu a športu SR
ID : APVV-14-0753
Pays : International

Références

Rinsho Byori. 2010 Mar;58(3):205-10
pubmed: 20408437
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
pubmed: 21296855
Biogerontology. 2005;6(4):271-81
pubmed: 16333761
J Clin Pathol. 1984 Sep;37(9):1050-4
pubmed: 6206098
Int J Cancer. 1988 Mar 15;41(3):359-63
pubmed: 2450069
Ann Med. 1999 Feb;31(1):34-45
pubmed: 10219712
Protein J. 2013 Feb;32(2):138-42
pubmed: 23397525
J Cell Biol. 2003 Jul 21;162(2):341-51
pubmed: 12860968
Exp Gerontol. 2014 Oct;58:154-8
pubmed: 25106097
Ann N Y Acad Sci. 2001 Apr;928:22-38
pubmed: 11795513
Science. 2004 Oct 1;306(5693):120-4
pubmed: 15459394
Exp Gerontol. 2000 Jul;35(4):473-9
pubmed: 10959035
Glycoconj J. 1997 Aug;14(5):569-76
pubmed: 9298689
Biotechnol Appl Biochem. 2016 Jul;63(4):457-64
pubmed: 26075587
J Cell Physiol. 2013 Aug;228(8):1665-75
pubmed: 23086799
Annu Rev Biochem. 1982;51:531-54
pubmed: 6287920
Z Gerontol Geriatr. 1997 May-Jun;30(3):220-5
pubmed: 9333453
J Proteomics Bioinform. 2012 May 31;5:127-134
pubmed: 23028207
Immunol Today. 1990 May;11(5):163-6
pubmed: 1692465
Exp Gerontol. 2010 Oct;45(10):738-43
pubmed: 20801208
J Steroid Biochem Mol Biol. 2009 Mar;114(1-2):78-84
pubmed: 19444937
Exp Gerontol. 2006 Nov;41(11):1094-107
pubmed: 17030107
Cell. 2006 Sep 8;126(5):855-67
pubmed: 16959566
Ann Clin Biochem. 2016 Jan;53(Pt 1):106-11
pubmed: 26071488
Nature. 1985 Mar 7-13;314(6006):53-7
pubmed: 2579340
Ann N Y Acad Sci. 1994 Sep 10;737:267-72
pubmed: 7524401
PLoS One. 2015 Jun 23;10(6):e0130470
pubmed: 26103567
Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5563-8
pubmed: 17372210
J Gerontol A Biol Sci Med Sci. 2017 Sep 1;72(9):1218-1225
pubmed: 28003373
J Biol Chem. 2002 Apr 12;277(15):13338-45
pubmed: 11823454
Anticancer Res. 2009 Sep;29(9):3705-12
pubmed: 19667168

Auteurs

Miloš Šunderić (M)

Institute for the Application of Nuclear Energy (INEP), University of Belgrade, Banatska 31b, 11080, Belgrade, Serbia. milos@inep.co.rs.

Martina Križáková (M)

Department of Glycobiotechnology, Institute of Chemistry, Slovak Academy of Sciences, Bratislava, Slovakia.

Vesna Malenković (V)

Clinical-Medical Centre "Bežanijska Kosa", Belgrade, Serbia.

Danica Ćujić (D)

Institute for the Application of Nuclear Energy (INEP), University of Belgrade, Banatska 31b, 11080, Belgrade, Serbia.

Jaroslav Katrlík (J)

Department of Glycobiotechnology, Institute of Chemistry, Slovak Academy of Sciences, Bratislava, Slovakia.

Olgica Nedić (O)

Institute for the Application of Nuclear Energy (INEP), University of Belgrade, Banatska 31b, 11080, Belgrade, Serbia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH